2022
DOI: 10.1245/s10434-022-12712-9
|View full text |Cite
|
Sign up to set email alerts
|

ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Abstract: Among women with newly diagnosed breast cancer seen in the multidisciplinary clinic without previous genetic test results, 95% accepted genetic counseling, with 93% of those counseled opting for genetic testing. Ninety-eight percent of STAT genetic test results were available prior to surgery to aid in decision-making (https://doi.org/10.1245/ s10434-022-12595-w).DISCLOSURES Irene Kang has accepted consulting fees and speaker bureau fees for Puma Biotechnology and Consulting fees for Bristol Myers Squibb. Keta… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles